ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

FATE Fate Therapeutics Inc

3,71
-0,09 (-2,37%)
Última atualização: 16:30:27
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Fate Therapeutics Inc FATE NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,09 -2,37% 3,71 16:30:27
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
3,76 3,65 3,83 3,80
mais cotações »

Notícias Recentes

Data Hora Fonte Título
04/06/202417:01GLOBEFate Therapeutics Reports New Employee Inducement Awards..
29/05/202417:01GLOBEFate Therapeutics to Present at 2024 Jefferies Global..
09/05/202417:01GLOBEFate Therapeutics Reports First Quarter 2024 Financial..
09/05/202409:30GLOBEFate Therapeutics Announces First Lupus Patient Treated in..
06/05/202409:00GLOBEFate Therapeutics to Webcast Conference Call Reporting First..
03/05/202417:30GLOBEFate Therapeutics Announces Presentation of FT522..
22/04/202417:30GLOBEFate Therapeutics Announces Presentation of FT819..
03/04/202409:00GLOBEFate Therapeutics to Present at 23rd Annual Needham Virtual..
02/04/202417:01GLOBEFate Therapeutics Reports New Employee Inducement Award..
19/03/202409:44GLOBEFate Therapeutics Announces Pricing of $100 Million..
05/03/202418:01GLOBEFate Therapeutics Reports New Employee Inducement Award..
01/03/202410:00GLOBEFate Therapeutics to Present at Upcoming March Investor..
26/02/202418:01GLOBEFate Therapeutics Reports Fourth Quarter and Full Year 2023..
15/02/202410:00GLOBEFate Therapeutics to Webcast Conference Call Reporting..
02/02/202418:01GLOBEFate Therapeutics Reports New Employee Inducement Awards..
08/01/202410:00GLOBEFate Therapeutics Announces Initiation of Phase 1 Clinical..
13/12/202319:00GLOBEFate Therapeutics Reports New Employee Inducement Grants..
08/11/202318:01GLOBEFate Therapeutics Reports Third Quarter 2023 Financial..
25/10/202309:00GLOBEFate Therapeutics to Webcast Conference Call Reporting Third..
31/08/202309:00GLOBEFate Therapeutics to Present at Upcoming September Investor..
08/08/202317:01GLOBEFate Therapeutics Reports Second Quarter 2023 Financial..
28/07/202309:00GLOBEFate Therapeutics to Webcast Conference Call Reporting..